Zobrazeno 1 - 10
of 34
pro vyhledávání: '"William F. Herblin"'
Publikováno v:
Life Sciences. 63:223-234
A novel binding site for angiotensin II has been identified in certain murine tissues. This site, denoted ATm, is distinct from both the AT1 and AT2 sites, as well as the various atypical sites that have been described. The site has a low affinity fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ce6dd87dde319b78885f457353a6b7
https://doi.org/10.1016/s0024-3205(98)00263-x
https://doi.org/10.1016/s0024-3205(98)00263-x
Autor:
Ulla Crickard, Janet L. Gross, Kristi Eidsvoog, Kent Crickard, William F. Herblin, Shashikant Lele, Mahmood Yoonessi
Publikováno v:
Gynecologic Oncology. 55:277-284
Basic fibroblast growth factor (bFGF) and other members of the FGF family share several biological properties that have the potential to mediate neoplastic cell growth. To test the hypothesis that bFGF may play a role in human ovarian cancer cell gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2d7d1375c4cad018c28788e37d066c1
https://doi.org/10.1006/gyno.1994.1290
https://doi.org/10.1006/gyno.1994.1290
Publikováno v:
Expert Opinion on Therapeutic Patents. 4:641-654
(1994). Overview Oncologic, Endocrine & Metabolic: Recent advances in angiogenesis inhibitors. Expert Opinion on Therapeutic Patents: Vol. 4, No. 6, pp. 641-654.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cdc14961016208a1b4cb094864db0fd
https://doi.org/10.1517/13543776.4.6.641
https://doi.org/10.1517/13543776.4.6.641
Autor:
William F. Herblin, Janet L. Gross
Publikováno v:
Molecular and chemical neuropathology. 21:329-336
Angiogenesis is a complex sequence of events leading to the formation of new capillaries. Although essential to maturation and wound healing, most angiogenesis in the adult is associated with pathological events, such as the development of solid tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9207335b87222d0790bd80a3c98e5817
https://doi.org/10.1007/bf02815359
https://doi.org/10.1007/bf02815359
Autor:
A. Yayon, Kristi Eidsvoog, P. Czerniak, Janet L. Gross, Daniel L. Dexter, B. A. Dusak, M. D. Diamond, T. Sun, William F. Herblin
Publikováno v:
JNCI: Journal of the National Cancer Institute. 85:121-131
Background Recombinant human basic fibroblast growth factor (rHu-bFGF) is known to stimulate proliferation in some tumor cells and to modulate tumor vascularization. Purpose The purpose of this study was to examine the possible role of this agent in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2859cf2d62bbd1ae3354739f1b9ae9aa
https://doi.org/10.1093/jnci/85.2.121
https://doi.org/10.1093/jnci/85.2.121
Publikováno v:
Cancer. 70:2673-2680
A prominent feature of some tumors of the central nervous system is angiogenesis. In this process, basic fibroblastic growth factor (bFGF) plays a key role. Surgical specimens of 23 human brain tumors were examined, by immunocytochemistry with a high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32dd90ab617a6ffddddd8c6fed57fd65
https://doi.org/10.1002/1097-0142(19921201)70:11<2673::aid-cncr2820701118>3.0.co
https://doi.org/10.1002/1097-0142(19921201)70:11<2673::aid-cncr2820701118>3.0.co
Autor:
John V. Duncia, Pancras C. Wong, David D. Christ, Pieter B.M.W.M. Timmermans, T. Bradford Barnes, Andrew T. Chiu, William F. Herblin
Publikováno v:
Cardiovascular Drug Reviews. 9:317-339
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f27ab5405c6040cb808a9c5967f5fe56
https://doi.org/10.1111/j.1527-3466.1991.tb00419.x
https://doi.org/10.1111/j.1527-3466.1991.tb00419.x
Autor:
William F. Herblin, Andrew T. Chiu, Dale E. McCall, Robert J. Ardecky, David J. Carini, John V. Duncia, Lori J. Pease, Pancras C. Wong, Ruth R. Wexler, Alexander L Johnson, Pieter B.M.W.M. Timmermans
Publikováno v:
American Journal of Hypertension. 4:299S-302S
The possibility of receptor heterogeneity in the angiotensin II (AII) system has been suggested previously, based on differences in Kd values or sensitivity to thiol reagents. One of the authors earliest indications was the frequent observation of in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c11d33f744a5405bfde7b08599904817
https://doi.org/10.1093/ajh/4.4.299s
https://doi.org/10.1093/ajh/4.4.299s
Publikováno v:
Arthritis & Rheumatism. 34:314-324
The interactions of interleukin-1 beta (IL-1 beta) and basic fibroblast growth factor (bFGF) with monolayer cultures of rabbit articular chondrocytes were examined. Both agonists resulted in a synergistic increase in prostanoid production, to levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d93d7b50acc4c058ccd5fab354e46551
https://doi.org/10.1002/art.1780340309
https://doi.org/10.1002/art.1780340309
Publikováno v:
Trends in Pharmacological Sciences. 12:55-62
Substantial progress has been made recently in the development of nonpeptide angiotensin II receptor antagonists, a goal that has long remained an unmet challenge. Pieter Timmermans and colleagues review the pharmacology and the course of events that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f727258fd1181bf6231015cfa72eb541
https://doi.org/10.1016/0165-6147(91)90498-h
https://doi.org/10.1016/0165-6147(91)90498-h